326 related articles for article (PubMed ID: 36869904)
1. The NMDA receptor antagonists memantine and ketamine as anti-migraine agents.
Podkowa K; Czarnacki K; Borończyk A; Borończyk M; Paprocka J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1371-1398. PubMed ID: 36869904
[TBL] [Abstract][Full Text] [Related]
2. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.
McCloud TL; Caddy C; Jochim J; Rendell JM; Diamond PR; Shuttleworth C; Brett D; Amit BH; McShane R; Hamadi L; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011611. PubMed ID: 26415966
[TBL] [Abstract][Full Text] [Related]
3. NMDA receptor antagonists for the treatment of neuropathic pain.
Collins S; Sigtermans MJ; Dahan A; Zuurmond WW; Perez RS
Pain Med; 2010 Nov; 11(11):1726-42. PubMed ID: 21044263
[TBL] [Abstract][Full Text] [Related]
4. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
[TBL] [Abstract][Full Text] [Related]
5. Ketamine and other glutamate receptor modulators for depression in adults.
Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of memantine.
Johnson JW; Kotermanski SE
Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
[TBL] [Abstract][Full Text] [Related]
7. Memantine Improves Recovery After Spreading Depolarization in Brain Slices and can be Considered for Future Clinical Trials.
Reinhart KM; Humphrey A; Brennan KC; Carlson AP; Shuttleworth CW
Neurocrit Care; 2021 Oct; 35(Suppl 2):135-145. PubMed ID: 34657268
[TBL] [Abstract][Full Text] [Related]
8. Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review.
Fluyau D; Revadigar N; Pierre CG
Drug Alcohol Depend; 2020 Mar; 208():107845. PubMed ID: 31978670
[TBL] [Abstract][Full Text] [Related]
9. Role of memantine in the prophylactic treatment of episodic migraine: A systematic review.
Mistry VM; Morizio PL; Pepin MJ; Bryan WE; Brown JN
Headache; 2021 Sep; 61(8):1207-1213. PubMed ID: 34352118
[TBL] [Abstract][Full Text] [Related]
10. The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects.
Maeng S; Zarate CA
Curr Psychiatry Rep; 2007 Dec; 9(6):467-74. PubMed ID: 18221626
[TBL] [Abstract][Full Text] [Related]
11. Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.
Glasgow NG; Povysheva NV; Azofeifa AM; Johnson JW
J Neurosci; 2017 Oct; 37(40):9686-9704. PubMed ID: 28877967
[TBL] [Abstract][Full Text] [Related]
12. Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjects.
Lepow L; Luckenbaugh DA; Park L; Henter ID; Zarate CA
J Psychiatr Res; 2017 Mar; 86():55-57. PubMed ID: 27914292
[No Abstract] [Full Text] [Related]
13. mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats.
Sabino V; Narayan AR; Zeric T; Steardo L; Cottone P
Behav Brain Res; 2013 Jun; 247():9-16. PubMed ID: 23466691
[TBL] [Abstract][Full Text] [Related]
14. Recent insights into the mode of action of memantine and ketamine.
Johnson JW; Glasgow NG; Povysheva NV
Curr Opin Pharmacol; 2015 Feb; 20():54-63. PubMed ID: 25462293
[TBL] [Abstract][Full Text] [Related]
15. Memantine binding to a superficial site on NMDA receptors contributes to partial trapping.
Kotermanski SE; Wood JT; Johnson JW
J Physiol; 2009 Oct; 587(Pt 19):4589-604. PubMed ID: 19687120
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
Lipton SA
Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913
[TBL] [Abstract][Full Text] [Related]
17. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465
[TBL] [Abstract][Full Text] [Related]
18. Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats.
Kotermanski SE; Johnson JW; Thiels E
Pharmacol Biochem Behav; 2013 Aug; 109():67-76. PubMed ID: 23665480
[TBL] [Abstract][Full Text] [Related]
19. Interaction of memantine and ketamine in morphine- and pentazocine-induced antinociception in mice.
Malec D; Mandryk M; Fidecka S
Pharmacol Rep; 2008; 60(2):149-55. PubMed ID: 18443375
[TBL] [Abstract][Full Text] [Related]
20. Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study.
Noruzzadeh R; Modabbernia A; Aghamollaii V; Ghaffarpour M; Harirchian MH; Salahi S; Nikbakht N; Noruzi N; Tafakhori A
Headache; 2016 Jan; 56(1):95-103. PubMed ID: 26638119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]